CERo Therapeutics Holdings, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-06-30 |
|---|---|
Revenue | $0 |
Gross Profit | -293 |
EBITDA | -2,138 |
EBIT | -2,431 |
Net Income | -2,448 |
Net Change In Cash | 0 |
Free Cash Flow | -3,537 |
Cash | 3,647 |
Basic Shares | 16,198 |
Annual Financials
| Values in thousands | 2022-12-31 | 2021-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -68 | -332 |
EBIT | -1,141 | -1,067 |
Net Income | -667 | -315 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -1,786 | -1,309 |
Cash | 42,141 | 1,098 |
Basic Shares | 6,769 | 22,981 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.15 |
2024-03-31 | -$0.15 |
2023-12-31 | -$0.04 |
2023-09-30 | -$0.05 |
